Multiple risk factors for cardiovascular disease and diabetes mellitus

被引:205
作者
Smith, Sidney C., Jr. [1 ]
机构
[1] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC 27599 USA
关键词
cardiovascular risk; metabolic syndrome; obesity; type 2 diabetes mellitus;
D O I
10.1016/j.amjmed.2007.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the past 25 years, obesity and diabetes mellitus have overtaken cigarette smoking, dyslipidemia, and hypertension as risk factors for coronary heart disease. Data from a Centers for Disease Control and Prevention (CDC) survey of 50 states revealed that, in 2000, the prevalence of obesity among US adults was approximately 20%, a 61% increase from the 1991 prevalence rate. Currently, most adults (>= 56%) are overweight, approximately 1 in 5 is obese, and 7.3% have diabetes. Overweight and obesity increase the risk for hospitalization and death from cardiovascular disease (CVD) and type 2 diabetes at all levels of risk and independently of other risk factors. In particular, abdominal obesity (assessed indirectly by measuring waist circumference) may be associated with clustering of cardiovascular and metabolic risk factors (i.e., hypertriglyceridemia, low high-density lipoprotein [HDL] cholesterol levels, high blood pressure, and elevated levels of fasting glucose) known as the metabolic syndrome. Patients with even minimal abnormalities in any 3 of the 5 risk factors for the metabolic syndrome are at heightened risk for CVD or diabetes. It is estimated that 47 million US adults, 25% of the population, have >= 3 metabolic syndrome components. Abdominal obesity is the most common, followed by low HDL cholesterol levels, high blood pressure, and high levels of triglycerides. The risk for disease increases over time as the number of metabolic syndrome characteristics accumulates; therefore, early intervention is warranted. Given the prevalence and potentially deadly consequences of the metabolic syndrome, it is imperative for physicians to recognize the presence of these risk factors in their patients and to familiarize themselves with the recommended treatment strategies. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:S3 / S11
页数:9
相关论文
共 34 条
  • [1] *AM OB ASS, 2002, AOA FACT SHEETS OBES
  • [2] [Anonymous], 1998, NIH PUBL
  • [3] International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
    Bhatt, DL
    Steg, PG
    Ohman, EM
    Hirsch, AT
    Ikeda, Y
    Mas, JL
    Goto, S
    Liau, CS
    Richard, AJ
    Röther, J
    Wilson, PWF
    Andersen-Dalheim, H
    Anderson, P
    Anell, B
    Arber, S
    Armstrong, K
    Arnot, D
    Baldam, A
    Barratt, I
    Barresi, S
    Beder, J
    Benson, M
    Bergman, F
    Best, J
    Bhasim, R
    Bovell, G
    Bowman, N
    Brkic, M
    Bromberger, D
    Brown, D
    Brown, J
    Brownstein, M
    Bruce, A
    Buonopane, J
    Burns, S
    Butler, A
    Byrne, D
    Carson, J
    Cassimatis, P
    Chaffey, G
    Chambers, D
    Chan, WJ
    Chan, B
    Cheatham, J
    Chen, R
    Cheong, B
    Cheung, C
    Chin, J
    Chiu, A
    Choo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02): : 180 - 189
  • [4] Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
    Capewell, S
    Morrison, CE
    McMurray, JJ
    [J]. HEART, 1999, 81 (04) : 380 - 386
  • [5] Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993
    Capewell, S
    Beaglehole, R
    Seddon, M
    McMurray, J
    [J]. CIRCULATION, 2000, 102 (13) : 1511 - 1516
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] Why model coronary heart disease?
    Critchley, JA
    Capewell, S
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 (02) : 110 - 116
  • [8] Preventing cardiovascular disease and diabetes - A call to action from the American Diabetes Association and the American Heart Association
    Eckel, Robert H.
    Kahn, Richard
    Robertson, Rose Marie
    Rizza, Robert A.
    [J]. CIRCULATION, 2006, 113 (25) : 2943 - 2946
  • [9] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
    Ford, ES
    Giles, WH
    Dietz, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03): : 356 - 359
  • [10] Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
    Grundy, SM
    Brewer, HB
    Cleeman, JI
    Smith, SC
    Lenfant, C
    [J]. CIRCULATION, 2004, 109 (03) : 433 - 438